News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
375,016 Results
Type
Article (24669)
Company Profile (32)
Press Release (350315)
Multimedia
Podcasts (77)
Webinars (6)
Section
Business (121471)
Career Advice (1503)
Deals (18297)
Drug Delivery (54)
Drug Development (43668)
Employer Resources (108)
FDA (9042)
Job Trends (8682)
News (195459)
Policy (17932)
Tag
2024 BioCapital Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (3)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (1591)
Academic (1)
Accelerated approval (4)
Adcomms (11)
Allergies (52)
Alliances (33460)
ALS (55)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (62)
Approvals (9074)
Artificial intelligence (160)
Autoimmune disease (13)
Automation (12)
Bankruptcy (178)
Best Places to Work (7268)
BIOSECURE Act (5)
Biosimilars (51)
Biotechnology (25)
Bladder cancer (42)
Brain cancer (12)
Breast cancer (173)
Cancer (1349)
Cardiovascular disease (109)
Career advice (1278)
Career pathing (22)
CAR-T (80)
Cell therapy (266)
Cervical cancer (13)
Clinical research (35411)
Collaboration (594)
Compensation (114)
Complete response letters (8)
COVID-19 (1520)
CRISPR (26)
C-suite (113)
Cystic fibrosis (55)
Data (1423)
Decentralized trials (2)
Denatured (26)
Depression (23)
Diabetes (177)
Diagnostics (3453)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (35)
Drug discovery (74)
Drug pricing (53)
Drug shortages (18)
Duchenne muscular dystrophy (72)
Earnings (55051)
Editorial (30)
Employer branding (14)
Employer resources (96)
Events (55583)
Executive appointments (396)
FDA (9784)
Featured Employer (17)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (413)
Gene editing (59)
Generative AI (17)
Gene therapy (215)
GLP-1 (423)
Government (2455)
Grass and pollen (3)
Guidances (40)
Healthcare (10747)
Huntington's disease (12)
IgA nephropathy (16)
Immunology and inflammation (69)
Indications (21)
Infectious disease (1606)
Inflammatory bowel disease (87)
Inflation Reduction Act (8)
Influenza (30)
Intellectual property (60)
Interviews (271)
IPO (8565)
IRA (26)
Job creations (1768)
Job search strategy (1068)
Kidney cancer (3)
Labor market (19)
Layoffs (211)
Leadership (15)
Legal (4674)
Liver cancer (35)
Lung cancer (201)
Lymphoma (91)
Machine learning (2)
Management (37)
Manufacturing (171)
MASH (44)
Medical device (6815)
Medtech (6819)
Mergers & acquisitions (10105)
Metabolic disorders (430)
Multiple sclerosis (52)
NASH (9)
Neurodegenerative disease (50)
Neuropsychiatric disorders (13)
Neuroscience (1130)
NextGen: Class of 2025 (3611)
Non-profit (2996)
Northern California (1472)
Now hiring (7)
Obesity (219)
Opinion (156)
Ovarian cancer (41)
Pain (48)
Pancreatic cancer (47)
Parkinson's disease (82)
Partnered (12)
Patents (135)
Patient recruitment (57)
Peanut (28)
People (28926)
Pharmaceutical (11)
Pharmacy benefit managers (8)
Phase I (10539)
Phase II (15068)
Phase III (12694)
Pipeline (886)
Policy (82)
Postmarket research (1710)
Preclinical (4595)
Press Release (31)
Prostate cancer (83)
Psychedelics (18)
Radiopharmaceuticals (151)
Rare diseases (240)
Real estate (2619)
Recruiting (41)
Regulatory (12005)
Reports (17)
Research institute (1424)
Resumes & cover letters (228)
Rett syndrome (2)
RNA editing (2)
RSV (31)
Schizophrenia (42)
Series A (72)
Series B (40)
Service/supplier (3)
Sickle cell disease (36)
Southern California (1272)
Special edition (7)
Spinal muscular atrophy (90)
Sponsored (17)
Startups (1591)
State (1)
Stomach cancer (9)
Supply chain (31)
Tariffs (12)
The Weekly (50)
United States (13117)
Vaccines (452)
Venture capitalists (18)
Weight loss (138)
Women's health (20)
Worklife (12)
Date
Last 7 days (286)
Last 30 days (1352)
Last 365 days (19759)
2025 (5861)
2024 (20756)
2023 (22922)
2022 (29034)
2021 (31048)
2020 (30223)
2019 (26485)
2018 (19631)
2017 (18155)
2016 (17799)
2015 (20210)
2014 (16871)
2013 (14759)
2012 (14543)
2011 (14055)
2010 (13211)
Location
Africa (562)
Alabama (39)
Alaska (5)
Arizona (84)
Arkansas (7)
Asia (21730)
Australia (3618)
California (3317)
Canada (1176)
China (292)
Colorado (178)
Connecticut (179)
Delaware (84)
Europe (51506)
Florida (586)
Georgia (138)
Idaho (21)
Illinois (295)
India (19)
Indiana (199)
Iowa (3)
Japan (103)
Kansas (57)
Kentucky (8)
Louisiana (4)
Maine (28)
Maryland (486)
Massachusetts (2560)
Michigan (124)
Minnesota (178)
Missouri (31)
Montana (8)
Nebraska (10)
Nevada (31)
New Hampshire (30)
New Jersey (1137)
New Mexico (12)
New York (1005)
North Carolina (604)
North Dakota (3)
Northern California (1472)
Ohio (108)
Oklahoma (12)
Oregon (20)
Pennsylvania (789)
Puerto Rico (2)
Rhode Island (19)
South America (769)
South Carolina (12)
Southern California (1272)
Tennessee (67)
Texas (486)
Utah (113)
Virginia (77)
Washington D.C. (39)
Washington State (313)
West Virginia (2)
Wisconsin (26)
375,016 Results for "ernst and young llp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Aurion Biotech CEO Greg Kunst Named Ernst & Young 2024 Entrepreneur of the Year Mountain West Region
Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, announced that CEO Greg Kunst has been named winner of the Ernst & Young 2024 Entrepreneur of the Year award for the Mountain West Region.
June 17, 2024
·
3 min read
Lone Star Bio
Castle Biosciences’ Founder, President and CEO Derek Maetzold Named an EY Entrepreneur Of The Year® 2024 Gulf South Award Winner
Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced that its founder, president and chief executive officer, Derek Maetzold, has been named by Ernst & Young LLP as an Entrepreneur Of The Year® 2024 Gulf South Award winner.
June 14, 2024
·
5 min read
Press Releases
ACARIZAX® approved in Canada for treatment of young children
March 10, 2025
·
2 min read
Press Releases
Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
April 16, 2025
·
1 min read
Press Releases
ME Therapeutics Announces It Has Engaged Lucosky Brookman LLP to Explore a Listing on the NASDAQ or NYSE
March 3, 2025
·
4 min read
Press Releases
Sunflower Therapeutics Engages PharmNXT Biotech LLP as Distributor for the Daisy Petal™ Perfusion Bioreactor System
February 26, 2025
·
3 min read
BioMidwest
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
Lifecore Biomedical, Inc. announced that Ernst & Young LLP, the Company’s independent registered public accounting firm for the fiscal year ended May 28, 2023, determined that it declined to stand for reappointment as the Company’s independent registered public accounting firm for the Company’s fiscal year ending May 26, 2024 following the filing of the Company’s Annual Report on Form 10-K.
March 26, 2024
·
2 min read
Press Releases
FDA approves ODACTRA® for the treatment of house dust mite allergy in young children
February 28, 2025
·
2 min read
Press Releases
So-Young Reschedules Release of Fourth Quarter and Full Year 2024 Financial Results to March 28, 2025
March 18, 2025
·
2 min read
Press Releases
ZORYVE® Cream 0.15% Approved by Health Canada for the Treatment of Mild to Moderate Atopic Dermatitis in Adults and Children as Young as Six Years of Age
March 17, 2025
·
10 min read
1 of 37,502
Next
